Epidemiology and tumor characteristics of gastrointestinal stromal tumors in KRG territories
Abstract
Keywords
Full Text:
PDFReferences
Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279(5350): 577–580.
Rasul KI, Jassoum SB, Hamad MY. Epidemiology and clinicopathological pattern of gastrointestinal stromal tumors in Qatar. J Chinese Clin Med 2008; 3: 117–180.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: Pathology and prognosis at different sites. In Seminars in diagnostic pathology 2006 May 1, WB Saunders. doi: 10.1053/j.semdp.2006.09.001.
Demetri GD, Von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 2010; 8: S1–S44.
Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299(5607): 708–710. doi: 10.1126/science.1079666.
Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 2008; 53(3): 245–266. doi: 10.1111/j.1365-2559.2008.02977.x.
Lasota J, Corless CL, Heinrich MC, Debiec-Rychter M, Sciot R, et al. Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases. Mod Pathol 2008; 21(4): 476. doi: 10.1038/modpathol.2008.2.
Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, et al. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. Cancer 2005; 103(4): 821–829. doi: 10.1002/cncr.20862.
Demetri GD, Von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, et al. NCCN Task Force report: Update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 2010; 8: S1–41.
Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol 2016; 40: 39–46. doi: 10.1016/j.canep.2015.10.031.
Steigen SE, Eide TJ. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway. APMIS 2006; 114(3): 192–200. doi: 10.1111/j.1600-0463.2006.apm_261.x.
Chan KH, Chan CW, Chow WH, Kwan WK, Kong CK, et al. Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World J Gastroenterol 2006; 12(14): 2223–2228. doi: 10.3748/wjg.v12.i14.2223.
Lv M, Wu C, Zheng Y, Zhao N. Incidence and survival analysis of gastrointestinal stromal tumors in shanghai: A population-based study from 2001 to 2010. Gastroenterol Res Pract 2014; 2014 (3): 834136. doi: 10.1155/2014/834136.
Al-Thani H, El-Menyar A, Rasul KI, Al-Sulaiti M, El-Mabrok J, et al. Clinical presentation, management and outcomes of gastrointestinal stromal tumors. Int J Surg 2014; 12(10): 1127–1133. doi: 10.1016/j.ijsu.2014.08.351.
DOI: http://dx.doi.org/10.30564/amor.v4i2.174
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Fahmi M. Salih, Kakil Ibrahim Rasul

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.